State Opioid and Stimulant Response (SOS) Grants (Ohio) is sponsored by Ohio Department of Behavioral Health (DBH) / SAMHSA. Ohio's iteration of the SAMHSA State Opioid Response (SOR) grant program, titled "State Opioid and Stimulant Response" or SOS 3.0, implements tailored approaches in prevention, harm reduction, treatment, and recovery supports for opioid use disorder, stimulant use disorder, and/or co-occurring disorders. It aligns state-level efforts with community partners for data-driven approaches.

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.